New method makes vaccines stable at tropical temperatures

February 17, 2010, Wellcome Trust
A cheap and simple way of making vaccines stable -- even at tropical temperatures -- has been proven to work by scientists at Oxford University. Credit: Nova Bio-Pharma Technologies

A simple and cheap way of making vaccines stable - even at tropical temperatures - has been developed by scientists at Oxford University and Nova Bio-Pharma Technologies.

The British technology has the potential to revolutionise vaccination efforts, particularly in the developing world where infectious diseases kill millions of people every year, by removing the need for fridges, freezers and associated health infrastructure.

The work, funded by the Grand Challenges in Global Health partnership with other funds from the Wellcome Trust, is published in the journal Science Translational Medicine.

Preparing vaccines that do not need refrigeration has been identified as one of the major unsolved problems in global health.

'Currently vaccines need to be stored in a fridge or freezer,' explains lead author Dr Matt Cottingham of the Jenner Institute at the University of Oxford. 'That means you need a clinic with a nurse, a fridge and an electricity supply, and refrigeration lorries for distribution.

'If you could ship vaccines at normal temperatures, you would greatly reduce cost and hugely improve access to vaccines,' he says. 'You could even picture someone with a backpack taking vaccine doses on a bike into remote villages.'

In the proof-of-concept study, the team showed it was possible to store two different virus-based vaccines on sugar-stabilised membranes for 4 months at 45°C without any degradation. The vaccines could be kept for a year and more at 37°C with only tiny losses in the amount of viral vaccine re-obtained from the membrane.

'We've developed a very simple way of heat-stabilising vaccines and shown it works for two viruses that are being used as the basis for novel vaccines in development,' says principal investigator Professor Adrian Hill of Oxford University. 'This is so exciting scientifically because these viruses are fragile. If we are able to stabilise these, other vaccines are likely to be easier.'

The team's method involves mixing the vaccine with the sugars trehalose and sucrose. The mixture is then left to slowly dry out on a simple filter or membrane. As it dries and the water evaporates the vaccine mixture turns into a syrup and then fully solidifies on the membrane.

The thin sugary film that forms on the membrane preserves the active part of the vaccine in a kind of suspended animation, protected from degradation even at high temperature. Flushing the membrane with water rehydrates the vaccine from the membrane in an instant.

A cheap and simple way of making vaccines stable -- even at tropical temperatures -- has been proven to work by scientists at Oxford University. The British technology, developed by specialist manufacturer Nova Bio-Pharma Technologies, removes the need for fridges, freezers and associated health infrastructure. It has the potential to revolutionize vaccination efforts - particularly in the developing world where infectious diseases kill millions of people every year. Credit: Nova Bio-Pharma Technologies

'The beauty of this approach is that a simple plastic cartridge, containing the membrane with vaccine dried on, can be placed on the end of a syringe,' explains Dr Cottingham. 'Pushing a liquid solution from the syringe over the membrane would then release the and inject it into the patient.'

The process is general and could be used for many types of vaccines and sensitive biological agents.

Professor Hill adds: 'The World Health Organisation's immunisation program vaccinates nearly 80% of the children born today against six killer diseases: polio, diphtheria, tuberculosis, whooping cough, measles and tetanus. One of the biggest costs is maintaining what's called the cold chain - making sure vaccines are refrigerated all the way from the manufacturer to the child, whether they are in the Western world or the remotest village in Africa. If most or all of the vaccines could be stabilised at high temperatures, it would not only remove cost, more children would be vaccinated.'

Related Stories

Recommended for you

Forces from fluid in the developing lung play an essential role in organ development

January 23, 2018
It is a marvel of nature: during gestation, multiple tissue types cooperate in building the elegantly functional structures of organs, from the brain's folds to the heart's multiple chambers. A recent study by Princeton researchers ...

Anemia discovery offers new targets to treat fatigue in millions

January 22, 2018
A new discovery from the University of Virginia School of Medicine has revealed an unknown clockwork mechanism within the body that controls the creation of oxygen-carrying red blood cells. The finding sheds light on iron-restricted ...

More surprises about blood development—and a possible lead for making lymphocytes

January 22, 2018
Hematopoietic stem cells (HSCs) have long been regarded as the granddaddy of all blood cells. After we are born, these multipotent cells give rise to all our cell lineages: lymphoid, myeloid and erythroid cells. Hematologists ...

How metal scaffolds enhance the bone healing process

January 22, 2018
A new study shows how mechanically optimized constructs known as titanium-mesh scaffolds can optimize bone regeneration. The induction of bone regeneration is of importance when treating large bone defects. As demonstrated ...

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.